Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series
- PMID: 24845114
- DOI: 10.1111/jcpt.12179
Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series
Abstract
What is known and objective: Cannabidiol (CBD) is the main non-psychotropic component of the Cannabis sativa plant. REM sleep behaviour disorder (RBD) is a parasomnia characterized by the loss of muscle atonia during REM sleep associated with nightmares and active behaviour during dreaming. We have described the effects of CBD in RBD symptoms in patients with Parkinson's disease.
Cases summary: Four patients treated with CBD had prompt and substantial reduction in the frequency of RBD-related events without side effects.
What is new and conclusion: This case series indicates that CBD is able to control the symptoms of RBD.
Keywords: Parkinson's disease; cannabidiol; rapid eye movement sleep behaviour disorder.
© 2014 John Wiley & Sons Ltd.
Similar articles
-
Cannabidiol for Rapid Eye Movement Sleep Behavior Disorder.Mov Disord. 2021 Jul;36(7):1711-1715. doi: 10.1002/mds.28577. Epub 2021 Mar 22. Mov Disord. 2021. PMID: 33754375 Clinical Trial.
-
The Effect of Cannabidiol for Restless Legs Syndrome/Willis-Ekbom Disease in Parkinson's Disease Patients with REM Sleep Behavior Disorder: A Post Hoc Exploratory Analysis of Phase 2/3 Clinical Trial.Cannabis Cannabinoid Res. 2023 Apr;8(2):374-378. doi: 10.1089/can.2021.0158. Epub 2022 Jun 24. Cannabis Cannabinoid Res. 2023. PMID: 35749710 Clinical Trial.
-
Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases.Brain. 2000 Feb;123 ( Pt 2):331-9. doi: 10.1093/brain/123.2.331. Brain. 2000. PMID: 10648440
-
REM sleep behaviour disorder.Nat Rev Dis Primers. 2018 Aug 30;4(1):19. doi: 10.1038/s41572-018-0016-5. Nat Rev Dis Primers. 2018. PMID: 30166532 Review.
-
Recent data on rapid eye movement sleep behavior disorder in patients with Parkinson disease: analysis of behaviors, movements, and periodic limb movements.Sleep Med. 2013 Aug;14(8):749-53. doi: 10.1016/j.sleep.2012.07.005. Epub 2012 Sep 28. Sleep Med. 2013. PMID: 23021864 Review.
Cited by
-
Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research.Sports Med Open. 2020 Jul 6;6(1):27. doi: 10.1186/s40798-020-00251-0. Sports Med Open. 2020. PMID: 32632671 Free PMC article. Review.
-
Cannabinoids in Neurology - Position paper from Scientific Departments from Brazilian Academy of Neurology.Arq Neuropsiquiatr. 2021 Apr;79(4):354-369. doi: 10.1590/0004-282X-ANP-2020-0432. Arq Neuropsiquiatr. 2021. PMID: 34133518 Free PMC article.
-
Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment.Front Pharmacol. 2021 Nov 12;12:734613. doi: 10.3389/fphar.2021.734613. eCollection 2021. Front Pharmacol. 2021. PMID: 34867342 Free PMC article. Review.
-
Cannabinoids in Parkinson's Disease.Cannabis Cannabinoid Res. 2017 Feb 1;2(1):21-29. doi: 10.1089/can.2017.0002. eCollection 2017. Cannabis Cannabinoid Res. 2017. PMID: 28861502 Free PMC article. Review.
-
Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life.Front Pharmacol. 2017 May 11;8:259. doi: 10.3389/fphar.2017.00259. eCollection 2017. Front Pharmacol. 2017. PMID: 28553229 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
